• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DJ-1 通过激活 SRC/ERK/uPA 促进胰腺癌细胞的侵袭和转移。

DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA.

机构信息

Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

出版信息

Carcinogenesis. 2012 Mar;33(3):555-62. doi: 10.1093/carcin/bgs002. Epub 2012 Jan 4.

DOI:10.1093/carcin/bgs002
PMID:22223849
Abstract

A major hallmark of pancreatic ductal adenocarcinoma (PDAC) is extensive local tumor invasion and early systemic dissemination. DJ-1 has been shown to prevent cell death via the Akt pathway, thereby playing an important role in cancer progression and Parkinson's disease development. Here, we investigated the role of DJ-1 in tumor invasion and metastasis of pancreatic cancer and showed that DJ-1 is upregulated in 68.5% of pancreatic cancer specimens, correlated with tumor stage and predictive of short overall survival. Knockdown of DJ-1 expression in two PDAC cell lines reduced cell migration and invasion potential in vitro and inhibited metastasis in vivo. Knockdown of DJ-1 led to cytoskeleton disruption and diminished urokinase plasminogen activator (uPA) activity and expression, without affecting plasminogen activator inhibitor-1 and uPA receptor (uPAR) expression. All these effects were reversed by restoration of DJ-1 expression. In determining the pathway through which DJ-1 regulated cell migration and invasion, DJ-1 was found not to regulate Akt phosphorylation. Rather, it promoted extracellular signal-regulated kinase (ERK) and SRC phosphorylation. Inhibition of the ERK pathway in PDAC mimicked the effects of DJ-1 on cell migration, invasion, actin cytoskeleton and uPA/uPAR system and abolished the effects on promoting PDAC cell invasion and migration. These data represent the first identification of an important function of DJ-1, which is to regulate the invasion and metastasis properties of PDAC through the ERK/uPA cascade.

摘要

胰腺导管腺癌 (PDAC) 的一个主要特征是广泛的局部肿瘤浸润和早期全身扩散。DJ-1 已被证明可通过 Akt 途径防止细胞死亡,从而在癌症进展和帕金森病发展中发挥重要作用。在这里,我们研究了 DJ-1 在胰腺癌肿瘤侵袭和转移中的作用,并表明 DJ-1 在 68.5%的胰腺癌标本中上调,与肿瘤分期相关,并预测总生存期短。在两种 PDAC 细胞系中敲低 DJ-1 表达可降低体外细胞迁移和侵袭潜能,并抑制体内转移。DJ-1 敲低导致细胞骨架破坏,并降低尿激酶纤溶酶原激活物 (uPA) 活性和表达,而不影响纤溶酶原激活物抑制剂-1 和 uPA 受体 (uPAR) 的表达。所有这些影响均可通过 DJ-1 表达的恢复而逆转。在确定 DJ-1 调节细胞迁移和侵袭的途径时,发现 DJ-1 不调节 Akt 磷酸化。相反,它促进细胞外信号调节激酶 (ERK) 和 SRC 磷酸化。在 PDAC 中抑制 ERK 途径可模拟 DJ-1 对细胞迁移、侵袭、肌动蛋白细胞骨架和 uPA/uPAR 系统的影响,并消除对促进 PDAC 细胞侵袭和迁移的影响。这些数据首次确定了 DJ-1 的一个重要功能,即通过 ERK/uPA 级联调节 PDAC 的侵袭和转移特性。

相似文献

1
DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA.DJ-1 通过激活 SRC/ERK/uPA 促进胰腺癌细胞的侵袭和转移。
Carcinogenesis. 2012 Mar;33(3):555-62. doi: 10.1093/carcin/bgs002. Epub 2012 Jan 4.
2
Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.尿激酶型纤溶酶原激活物受体的抑制通过ERK/p38信号通路的调节抑制胰腺腺癌细胞的增殖和迁移。
Int J Biochem Cell Biol. 2009 Aug-Sep;41(8-9):1731-8. doi: 10.1016/j.biocel.2009.03.004. Epub 2009 Mar 21.
3
Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.白细胞介素-1α通过调节α6β1整合素和尿激酶型纤溶酶原激活剂受体的表达增强胰腺癌细胞的侵袭行为。
BMC Cell Biol. 2006 Feb 20;7:8. doi: 10.1186/1471-2121-7-8.
4
Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.生长因子及尿激酶型纤溶酶原激活物系统在胰腺导管腺癌中的预后意义
Pancreas. 2008 Mar;36(2):160-7. doi: 10.1097/MPA.0b013e31815750f0.
5
Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.靶向人胰腺癌细胞中的尿激酶型纤溶酶原激活物受体可抑制c-Met和胰岛素样生长因子-I受体介导的迁移、侵袭以及小鼠原位肿瘤生长。
Cancer Res. 2005 Sep 1;65(17):7775-81. doi: 10.1158/0008-5472.CAN-05-0946.
6
uPA/uPAR downregulation inhibits radiation-induced migration, invasion and angiogenesis in IOMM-Lee meningioma cells and decreases tumor growth in vivo.uPA/uPAR下调抑制IOMM-Lee脑膜瘤细胞中辐射诱导的迁移、侵袭和血管生成,并降低体内肿瘤生长。
Int J Oncol. 2008 Nov;33(5):937-47.
7
[Correlation of p38 mitogen-activated protein kinase signal transduction pathway to uPA expression in breast cancer].[乳腺癌中p38丝裂原活化蛋白激酶信号转导通路与尿激酶型纤溶酶原激活剂表达的相关性]
Ai Zheng. 2007 Jan;26(1):48-53.
8
CCDC88A, a prognostic factor for human pancreatic cancers, promotes the motility and invasiveness of pancreatic cancer cells.CCDC88A作为人类胰腺癌的一个预后因素,可促进胰腺癌细胞的运动性和侵袭性。
J Exp Clin Cancer Res. 2016 Dec 5;35(1):190. doi: 10.1186/s13046-016-0466-0.
9
Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells.磷脂酰肌醇3激酶/蛋白激酶B调节纤溶酶原激活物抑制剂-1和尿激酶之间的平衡,以促进SKOV-3卵巢癌细胞的迁移。
Gynecol Oncol. 2007 Feb;104(2):470-9. doi: 10.1016/j.ygyno.2006.08.048. Epub 2006 Oct 30.
10
Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.降钙素抑制乳腺癌细胞的侵袭:尿激酶型纤溶酶原激活剂(uPA)及uPA受体的作用
Int J Oncol. 2006 Apr;28(4):807-14.

引用本文的文献

1
[Enriching plasma exosomes for proteomic analysis using a phosphatidylserine-imprinted polymer].[使用磷脂酰丝氨酸印迹聚合物富集血浆外泌体用于蛋白质组学分析]
Se Pu. 2025 May;43(5):539-546. doi: 10.3724/SP.J.1123.2024.05003.
2
miR-199a/b-3p inhibits HCC cell proliferation and invasion through a novel compensatory signaling pathway DJ-1\Ras\PI3K/AKT.miR-199a/b-3p 通过一种新型的补偿信号通路 DJ-1\Ras\PI3K/AKT 抑制 HCC 细胞增殖和侵袭。
Sci Rep. 2024 Jan 2;14(1):224. doi: 10.1038/s41598-023-48760-8.
3
Targeting Periostin Expression Makes Pancreatic Cancer Spheroids More Vulnerable to Natural Killer Cells.
靶向骨膜蛋白表达使胰腺癌球体对自然杀伤细胞更敏感。
Biomedicines. 2023 Jan 19;11(2):270. doi: 10.3390/biomedicines11020270.
4
DJ-1 promotes osteosarcoma progression through activating CDK4/RB/E2F1 signaling pathway.DJ-1通过激活CDK4/RB/E2F1信号通路促进骨肉瘤进展。
Front Oncol. 2022 Nov 3;12:1036401. doi: 10.3389/fonc.2022.1036401. eCollection 2022.
5
The Potential Role of Exosomal Proteins in Prostate Cancer.外泌体蛋白在前列腺癌中的潜在作用
Front Oncol. 2022 Jun 7;12:873296. doi: 10.3389/fonc.2022.873296. eCollection 2022.
6
Exploration of the System-Level Mechanisms of the Herbal Drug FDY003 for Pancreatic Cancer Treatment: A Network Pharmacological Investigation.中药FDY003治疗胰腺癌的系统水平机制探索:一项网络药理学研究
Evid Based Complement Alternat Med. 2022 May 10;2022:7160209. doi: 10.1155/2022/7160209. eCollection 2022.
7
Moving beyond the Tip of the Iceberg: DJ-1 Implications in Cancer Metabolism.超越冰山一角:DJ-1 在癌症代谢中的作用。
Cells. 2022 Apr 23;11(9):1432. doi: 10.3390/cells11091432.
8
Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties.野生型和功能获得性突变 TP53 可以调节胰腺癌细胞对化疗药物、EGFR/Ras/Raf/MEK 和 PI3K/mTORC1/GSK-3 通路抑制剂、营养保健品的敏感性,并改变代谢特性。
Aging (Albany NY). 2022 Apr 27;14(8):3365-3386. doi: 10.18632/aging.204038.
9
Knockdown of the DJ-1 (7) gene sensitizes pancreatic cancer to erlotinib inhibition.敲低DJ-1(7)基因可使胰腺癌对厄洛替尼抑制作用敏感。
Mol Ther Oncolytics. 2021 Jan 26;20:364-372. doi: 10.1016/j.omto.2021.01.013. eCollection 2021 Mar 26.
10
DJ‑1 is a new prognostic marker and predicts chemotherapy efficacy in colorectal cancer.DJ-1 是一种新的预后标志物,可预测结直肠癌的化疗疗效。
Oncol Rep. 2020 Jul;44(1):77-90. doi: 10.3892/or.2020.7593. Epub 2020 Apr 23.